Johnson Fine Chemical Co., Ltd. (TPEX:7763)
187.50
-4.00 (-2.09%)
At close: May 29, 2026
Johnson Fine Chemical Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 1,016 | 1,023 | 1,011 | 911.77 | 1,065 | |
Revenue Growth (YoY) | -6.00% | 1.21% | 10.91% | -14.37% | - |
Cost of Revenue | 620.97 | 604.13 | 640.42 | 610.25 | 711.29 |
Gross Profit | 395.36 | 419.3 | 370.83 | 301.52 | 353.43 |
Selling, General & Admin | 110.36 | 106.97 | 116.44 | 104.27 | 107.11 |
Research & Development | 42.82 | 47.26 | 36.15 | 35.92 | 32.47 |
Operating Expenses | 153.09 | 153.51 | 152.59 | 141.11 | 140.15 |
Operating Income | 242.27 | 265.79 | 218.24 | 160.4 | 213.29 |
Interest Expense | -0.05 | -0.05 | -0.32 | -1.49 | -1.99 |
Interest & Investment Income | 6.11 | 5.49 | 3.93 | 1.82 | 0.28 |
Currency Exchange Gain (Loss) | 0.85 | 0.85 | -1.79 | 2.53 | 6.6 |
Other Non Operating Income (Expenses) | -12.37 | 9.42 | 10.44 | 10.64 | 7.53 |
EBT Excluding Unusual Items | 236.82 | 281.5 | 230.5 | 173.9 | 225.71 |
Gain (Loss) on Sale of Assets | -0.14 | -0.14 | -0.39 | -0.03 | -0.56 |
Pretax Income | 236.68 | 281.36 | 230.11 | 173.88 | 225.15 |
Income Tax Expense | 50.59 | 61.76 | 51.46 | 38.45 | 48.28 |
Net Income | 186.09 | 219.6 | 178.65 | 135.42 | 176.87 |
Net Income to Common | 186.09 | 219.6 | 178.65 | 135.42 | 176.87 |
Net Income Growth | -15.41% | 22.92% | 31.92% | -23.43% | - |
Shares Outstanding (Basic) | 60 | 60 | 59 | 57 | 56 |
Shares Outstanding (Diluted) | 60 | 60 | 59 | 58 | 56 |
Shares Change (YoY) | 0.67% | 1.60% | 2.68% | 1.93% | - |
EPS (Basic) | 3.11 | 3.66 | 3.03 | 2.36 | 3.14 |
EPS (Diluted) | 3.11 | 3.66 | 3.02 | 2.35 | 3.13 |
EPS Growth | -15.82% | 21.16% | 28.51% | -24.92% | - |
Free Cash Flow | 247.55 | 310.65 | 273.78 | 186.09 | 117.28 |
Free Cash Flow Per Share | 4.13 | 5.17 | 4.63 | 3.23 | 2.08 |
Dividend Per Share | 2.500 | 2.500 | 2.000 | 1.200 | 1.000 |
Dividend Growth | 25.00% | 25.00% | 66.67% | 20.00% | - |
Gross Margin | 38.90% | 40.97% | 36.67% | 33.07% | 33.20% |
Operating Margin | 23.84% | 25.97% | 21.58% | 17.59% | 20.03% |
Profit Margin | 18.31% | 21.46% | 17.67% | 14.85% | 16.61% |
Free Cash Flow Margin | 24.36% | 30.35% | 27.07% | 20.41% | 11.02% |
EBITDA | 290.84 | 317.52 | 272.2 | 213.22 | 253.5 |
EBITDA Margin | 28.62% | 31.03% | 26.92% | 23.39% | 23.81% |
D&A For EBITDA | 48.56 | 51.73 | 53.96 | 52.82 | 40.21 |
EBIT | 242.27 | 265.79 | 218.24 | 160.4 | 213.29 |
EBIT Margin | 23.84% | 25.97% | 21.58% | 17.59% | 20.03% |
Effective Tax Rate | 21.37% | 21.95% | 22.36% | 22.12% | 21.44% |